Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Extended-duration effects of GLP-1 RAs and multi-agonists on liver-associated outcomes involving cirrhosis development, HCC incidence, and death from hepatic causes are being elucidated through ongoing observational studies and long-term trial extensions [65-70]
They are not typically prescribed for individuals with type 1 diabetes, as the mechanism of action primarily targets insulin secretion and glucose regulation in type 2 diabetes
Some people also notice temporary hair thinning when starting GLP-1 treatment, which is usually tied to the pace of weight loss rather than the medication itself
Aspiration is uncommon, and large prospective studies are difficult to conduct
10.1091/mbc.e13-10-0563 Mol
